Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Effect of mycobacterial drug resistance patterns on patients' survival: a cohort study in Thailand.

Anuwatnonthakate A, Whitehead SJ, Varma JK, Silachamroon U, Kasetjaroen Y, Moolphate S, Limsomboon P, Inyaphong J, Suriyon N, Kavinum S, Chiengson N, Tunteerapat P, Kaewkungwal J.

Glob J Health Sci. 2013 Aug 22;5(6):60-72. doi: 10.5539/gjhs.v5n6p60.

2.

Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.

Báez-Saldaña R, Delgado-Sánchez G, García-García L, Cruz-Hervert LP, Montesinos-Castillo M, Ferreyra-Reyes L, Bobadilla-Del-Valle M, Canizales-Quintero S, Ferreira-Guerrero E, Téllez-Vázquez N, Montero-Campos R, Yanes-Lane M, Mongua-Rodriguez N, Martínez-Gamboa RA, Sifuentes-Osornio J, Ponce-de-León A.

PLoS One. 2016 Dec 28;11(12):e0168955. doi: 10.1371/journal.pone.0168955. eCollection 2016.

3.

Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.

Abebe G, Abdissa K, Abdissa A, Apers L, Agonafir M, de-Jong BC, Colebunders R.

BMC Res Notes. 2012 May 10;5:225. doi: 10.1186/1756-0500-5-225.

4.

Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-Herbwai M, Alrabiah F, Alrajhi AA, Abuljadayel N, Al-Thawadi S, Zumla A, Zignol M, Raviglione MC, Memish Z.

Antimicrob Agents Chemother. 2013 May;57(5):2161-6. doi: 10.1128/AAC.02403-12. Epub 2013 Mar 4.

5.

The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.

Hanrahan CF, Dorman SE, Erasmus L, Koornhof H, Coetzee G, Golub JE.

PLoS One. 2012;7(11):e49898. doi: 10.1371/journal.pone.0049898. Epub 2012 Nov 30. Erratum in: PLoS One. 2013;8(6). doi: 10.1371/annotation/47420ec0-db00-4994-a0de-86b5e5d713f4.

6.
7.
8.

Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.

Sungkanuparph S, Eampokalap B, Chottanapund S, Bed ST, Manosuthi W.

J Med Assoc Thai. 2007 May;90(5):884-8.

PMID:
17596041
9.

The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.

Seddon JA, Hesseling AC, Marais BJ, Jordaan A, Victor T, Schaaf HS.

Int J Tuberc Lung Dis. 2012 Jul;16(7):928-33. doi: 10.5588/ijtld.11.0679. Epub 2012 May 8.

PMID:
22583610
10.

[Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].

Sezen F, Albayrak N, Özkara Ş, Karagöz A, Alp A, Duyar Ağca F, İnan Süer A, Müderris T, Ceyhan İ, Durmaz R, Ertek M; Tüberküloz Laboratuvar Sürveyans Ağı Tulsa Çalışma Grubu, Tulsa.

Mikrobiyol Bul. 2015 Apr;49(2):143-55. Turkish.

12.

Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.

Coronel J, Roper MH, Herrera C, Bonilla C, Jave O, Gianella C, Sabogal I, Huancaré V, Leo E, Tyas A, Mendoza-Ticona A, Caviedes L, Moore DA.

Clin Microbiol Infect. 2014 Jun;20(6):536-41. doi: 10.1111/1469-0691.12401. Epub 2013 Nov 21.

13.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

14.

Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients.

Hongthiamthong P, Chuchottaworn C, Amatayakul N.

J Med Assoc Thai. 1994 Jul;77(7):363-7.

PMID:
7876754
15.

Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.

Reechaipichitkul W.

Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):570-4.

PMID:
12693593
16.

[The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance].

Tan S, Ding X, Tan Y, Cai X, Li Y.

Zhonghua Jie He He Hu Xi Za Zhi. 2014 Dec;37(12):915-8. Chinese.

PMID:
25609129
18.

Drug resistance among new smear-positive pulmonary tuberculosis cases in Thailand.

Kateruttanakul P, Unsematham S.

Int J Tuberc Lung Dis. 2013 Jun;17(6):814-7. doi: 10.5588/ijtld.12.0847.

PMID:
23676168
19.

Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study.

He XC, Zhang XX, Zhao JN, Liu Y, Yu CB, Yang GR, Li HC.

Medicine (Baltimore). 2016 Apr;95(15):e3336. doi: 10.1097/MD.0000000000003336.

20.

Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success.

Daniels JF, Khogali M, Mohr E, Cox V, Moyo S, Edginton M, Hinderaker SG, Meintjes G, Hughes J, De Azevedo V, van Cutsem G, Cox HS.

PLoS One. 2015 Nov 10;10(11):e0142873. doi: 10.1371/journal.pone.0142873. eCollection 2015.

Supplemental Content

Support Center